Read More

EMA’s Human Medicines Committee Has Started A Review Of The Medicine Ocaliva; Study 747-302 Failed To Show That Ocaliva Was More Effective Than Placebo, Additionally, Side Effects, Including Serious Ones, Occurred More Frequently In Patients

https://www.ema.europa.eu/en/documents/referral/ocaliva-article-20-procedure-review-ocaliva-started_en.pdf Review of Ocaliva started EMA's human medicines committee (CHMP) has started a review of the medicine

ICPT